Mode
Text Size
Log in / Sign up
N/A N=844 Randomized Other

Blood-borne Infection Screening in an Afghan Antenatal Population

Viral Hepatitis B · Contraception · Breast Feeding, Exclusive · Effects of; Lack of Care of Infants

Enrolled (actual)
844
Serious AEs
0.0%
Results posted
Mar 2014
Primary outcome: Primary: Utilization of Postpartum Contraception — 199; 213 participants — p=<0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Concentrated postpartum counseling (Behavioral)
Age
Pediatric, Adult, Older Adult · 14+ yrs
Sex
All
Sponsor
Columbia University
Primary completion
May 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Utilization of Postpartum Contraception
199; 213 <0.05 sig
SECONDARY
Correct Breastfeeding Practices to 1 Year
198; 240 <0.05 sig
SECONDARY
Completion of 9 Month Measles-mumps-rubella Vaccination on Time.
211; 235 0.05

Summary

Baseline information indicates there are measurable levels of hepatitis B SAg and low utilization of postpartum contraception, correct breastfeeding practices, or adherence to infant vaccination schedules in Kabul, Afghanistan. This intervention will randomize hospitals to assess the following aims: Aim 1: To determine whether the re-training and assignment of health care providers dedicated to intrapartum rapid testing and post-partum counseling will positively impact maternal and neonatal health indicators as compared to utilization of existing health providers for these services among women delivering in publish health maternity hospitals in Kabul, Afghanistan. Aim 2: To assess whether patients randomized to the intervention and their spouses perceive value in concentrated post-partum counseling. Aim 3: To investigate whether an intervention providing immediate post-partum provision of a long-acting family planning method would be feasible and acceptable to both men and women in Kabul, Afghanistan.

Eligibility Criteria

Inclusion Criteria

  • admitted for obstetric care
  • Dari or Pashto speaking
  • not previously participated in the study
  • in medically stable condition
  • accompanied by and have approval of a spouse
  • able to provide informed consent

Male participants must be the confirmed spouses of the female participants, have a working telephone, and able to provide informed consent.

Exclusion Criteria

  • medically unstable or imminently delivering (complete cervical dilation)
  • husband unavailable or does not approve participation
  • unable to provide consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01199601). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search